How did UnitedHealth perform financially in 2023?

Revenue reached $371.6 billion, up 14.6%, and earnings from operations rose 13.8% to $32.4 billion. GAAP diluted EPS was $23.86, and adjusted EPS was $25.12. Return on equity was 27%.

Why did the medical care ratio increase?

The full-year medical care ratio rose to 83.2% from 82.0%, mainly due to higher outpatient care utilization, primarily among seniors, and changes in business mix. Q4 reached 85%, and Q4 included $100 million of unfavorable reserve development.

What is the outlook for 2024?

Management affirmed the 2024 objectives from its November 2023 Investor Conference, excluding the impact of the pending Brazil sale. The sale is expected to close in the first half of 2024 and will bring a previously announced charge that affects GAAP net earnings.

What is the difference between GAAP and adjusted EPS?

Adjusted EPS excludes intangible asset amortization, net of tax. For FY2023, this adds $1.68 per share in amortization, less a $0.42 tax effect, bringing GAAP EPS of $23.86 to adjusted EPS of $25.12. Management views this as a better measure of underlying performance because amortization depends on acquisition timing.

How did membership change during 2023?

UnitedHealthcare served more than 1 million additional people overall. Senior and complex-needs offerings grew by 950,000 and commercial benefits grew by over 800,000, while state-based community programs declined by 700,000 due to Medicaid eligibility redeterminations.

UNH 8-K: Earnings & Results

01—Abstract

Summary

Summary of the 8-K filed January 12, 2024. Cited figures are marked; the original filing is the authoritative source.

UnitedHealth Group (UNH) reported strong full-year and fourth-quarter 2023 results, with broad-based growth across Optum and UnitedHealthcare.

Full-year 2023 revenue rose 14.6% year-over-year to $371.6 billion^a, and earnings from operations grew 13.8% to $32.4 billion. Diluted GAAP EPS was $23.86 for the full year and $5.83 for Q4, while adjusted EPS (excluding intangible amortization) was $25.12 and $6.16, respectively. Cash flow from operations was $29.1 billion, or 1.3 times net income, and the company returned $14.8 billion to shareholders through dividends and buybacks.

Return on equity was 27%^b. Profitability pressure was visible in the medical care ratio, which rose to 83.2% for the full year from 82.0% and reached 85% in Q4. Management attributed this to higher outpatient care utilization, primarily among seniors, and business mix shifts.

Q4 also included $100 million^c of unfavorable medical reserve development, offsetting $840 million of favorable full-year development. Consolidated operating margin compressed to 8.7% from 8.8%, and Q4 margin fell to 8.1% from 8.3%. UnitedHealthcare's operating margin held at 5.8% for the year, while Optum's declined to 7.0% from 7.7%.

Management affirmed its 2024 performance objectives from the November 2023 Investor Conference, excluding the pending sale of the Brazil operations, which is expected to close in the first half of 2024 and will carry a previously announced charge. Membership trends were mixed: UnitedHealthcare served over 1 million more people in 2023, but state-based community programs lost 700,000 members due to Medicaid eligibility redeterminations. Optum Insight's contract backlog grew to $32.1 billion^d, and Optum Rx adjusted scripts reached 1.54 billion for the year.

02—Key points

Key Highlights

Full-year 2023 revenue grew 14.6% to $371.6 billion, with double-digit growth at both Optum (+24%) and UnitedHealthcare (+12.7%).
Diluted GAAP EPS was $23.86 for FY2023 (Q4: $5.83); adjusted EPS was $25.12 (Q4: $6.16), up from $22.19 in FY2022.
Medical care ratio rose to 83.2% from 82.0% for the full year and 85% in Q4, driven by outpatient care for seniors and business mix.
Operating cash flow of $29.1 billion was 1.3x net income; $14.8 billion was returned to shareholders via dividends and buybacks.
2024 performance objectives were affirmed, excluding the Brazil divestiture, which is expected to close in 1H 2024 and will trigger a previously announced charge.
Medicaid redeterminations reduced state-based community membership by 700,000, while senior and complex-needs offerings grew by 950,000.
Optum Insight contract backlog reached $32.1 billion and Optum Rx adjusted scripts grew to 1.54 billion for the year.

03—Questions

Frequently Asked Questions

How did UnitedHealth perform financially in 2023?
Revenue reached $371.6 billion, up 14.6%, and earnings from operations rose 13.8% to $32.4 billion. GAAP diluted EPS was $23.86, and adjusted EPS was $25.12. Return on equity was 27%.
Why did the medical care ratio increase?
The full-year medical care ratio rose to 83.2% from 82.0%, mainly due to higher outpatient care utilization, primarily among seniors, and changes in business mix. Q4 reached 85%, and Q4 included $100 million of unfavorable reserve development.
What is the outlook for 2024?
Management affirmed the 2024 objectives from its November 2023 Investor Conference, excluding the impact of the pending Brazil sale. The sale is expected to close in the first half of 2024 and will bring a previously announced charge that affects GAAP net earnings.
What is the difference between GAAP and adjusted EPS?
Adjusted EPS excludes intangible asset amortization, net of tax. For FY2023, this adds $1.68 per share in amortization, less a $0.42 tax effect, bringing GAAP EPS of $23.86 to adjusted EPS of $25.12. Management views this as a better measure of underlying performance because amortization depends on acquisition timing.
How did membership change during 2023?
UnitedHealthcare served more than 1 million additional people overall. Senior and complex-needs offerings grew by 950,000 and commercial benefits grew by over 800,000, while state-based community programs declined by 700,000 due to Medicaid eligibility redeterminations.

04—Continue

← View all 8-K filings